|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.3 CNY | -0.10% |
|
+6.39% | +31.80% |
| 04-26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
| 04-25 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Jafron Biomedical Co.,Ltd. (SZSE:300529) announces a share repurchase program. Under the program, the company will repurchase up to CNY 500 million worth of its shares. The shares will be repurchased at a price not more than CNY 36.11 per share.
The purpose of the program is conversion of the company?s convertible bonds, ESOP, or equity incentives. The repurchase period will be not more than 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.80% | 3.14B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| +13.67% | 25.02B | |
| -0.32% | 24.96B |
JAFRON BIOMEDICAL CO.,LTD. 
